Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|September 7, 2023
Applications of Molecular Dynamics Simulations in Drug DiscoverySara AlRawashdeh, Khaled H BarakatMedicinal Research Reviews|May 4, 2017
Development of Safe Drugs: The hERG ChallengeSubha Kalyaanamoorthy, Khaled H BarakatJournal of Molecular Graphics & Modelling|January 21, 2023
Structural analysis of hERG channel blockers and the implications for drug designSara AlRawashdeh, Suryanarayanan Chandrasekaran, Khaled H BarakatEuropean Journal of Medical Research|July 3, 2024
Targeting cytotoxic lymphocyte antigen 4 (CTLA-4) in breast cancerMaryam Jama, Yasser Tabana, Khaled H BarakatCurrent Pharmaceutical Design|April 21, 2016
Modelling DNA Repair Pathways: Recent Advances and Future DirectionsFrancesco Gentile, Jack A Tuszynski, Khaled H BarakatJournal of Molecular Graphics & Modelling|March 4, 2016
New design of nucleotide excision repair (NER) inhibitors for combination cancer therapyFrancesco Gentile, Jack A Tuszynski, Khaled H BarakatBiochimica Et Biophysica Acta. General Subjects|September 26, 2018
Revealing the atomistic details behind the binding of B7-1 to CD28 and CTLA-4: A comprehensive protein-protein modelling studyAravindhan Ganesan, Tae Chul Moon, Khaled H BarakatInternational Journal of Molecular Sciences|May 2, 2018
Computational Characterization of Small Molecules Binding to the Human XPF Active Site and Virtual Screening to Identify Potential New DNA Repair Inhibitors Targeting the ERCC1-XPF EndonucleaseFrancesco Gentile, Khaled H Barakat, Jack A TuszynskiFrontiers in Molecular Biosciences|August 28, 2024
Computational insights into the mechanisms underlying structural destabilization and recovery in trafficking-deficient hERG mutantsSara AlRawashdeh, Farag E S Mosa, Khaled H BarakatDrug Discovery Today|May 8, 2012
DNA polymerase beta (pol β) inhibitors: a comprehensive overviewKhaled H Barakat, Melissa M Gajewski, Jack A TuszynskiPageof 4